Tuesday, April 28, 2020 - People living with HIV are among the most concerned with contracting the COVID19 virus and are asking if their underlying condition will make the pandemic condition's symptoms worse for them and potentially more deadly than average. Scientists have collected only about one or two month's worth of COVID19 data, therefore, it may be too early to make a definitive pronouncement but speculation has risen that not only are AIDS patients not at greater risk, but they may also be at an advantage if they have been taking Truvada to manage their immunosuppressed condition. According to Catie, Canada's source for HIV and hepatitis C information, Truvada is the name of a fixed-dose co-formulation of two anti-HIV drugs: tenofovir and FTC all in one pill. Truvada is used as part of combination therapy for people with HIV. Some doctors may also prescribe Truvada to HIV-negative people as part of a package of HIV prevention tools to help reduce the risk of HIV transmission."
Researchers are looking at the anti-viral medication as a possible way to mitigate the symptoms of the Coronavirus. Doctors in New York, the pandemic's US epicenter, treating a large HIV-positive population have noticed that very few have the virus and that the symptoms of those who do are quite unremarkable. Clinical trials are underway in Spain, China, and Switzerland to test whether Truvada could be used as a viable Coronavirus therapy, perhaps taken as a pre-exposure prophylactic measure. Truvada may weaken the immune system sufficiently that the body avoids what is being termed "Cytokine storm syndrome" currently identified as the cause of death for most who die from the Coronavirus. Truvada attorneys representing people nationwide offer a free no obligation consultation and work on contingency.
Cytokine storm syndrome is when the body's immune system overwhelms its internal organs and destroys them in its mission to destroy the virus, much like sepsis. The National Institute of Health describes Cytokine Storm Syndrome (CSS) as: "Today we reserve the moniker "sepsis" to refer to overwhelming inflammation in the context of systemic infection (although even this definition can be ambiguous). The term "Cytokine Storm Syndrome" (CSS) was developed to accommodate the observation that multiple inflammatory causes can result in a disease that appears very similar to sepsis. The unifying feature of CSS is a clinical and laboratory phenotype suggestive of massive inflammation progressing to multiple organ dysfunction syndromes (MODS) and eventually death, a final common pathway." In other words, the body overreacts to the virus and the patient winds up killing themselves.
Before asking your doctor for a Truvada prescription to ward off the Coronavirus, be aware that Gilead, the maker of Truvada, failed to warn patients that were HIV positive that the drug may cause kidney failure and bone density loss. Lawsuits have been filed by plaintiffs that have suffered multiple bone fractures or kidney failure allegedly from taking Truvada. Gilead's negligence has been brought to light recently when the purpose of taking the drug was extended from those currently with AIDS to HIV-negative patients who wished to prevent transmission of the disease from their sexual partner. Truvada is being given away for free to HIV-negative homosexual men and women that desire safer sexual relations.
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.